Skip to content

Analysis of the factors of decline in ADL among inpatients: Using COVID-19 Registry Data

Analysis of the factors of decline in ADL among inpatients: Using COVID-19 Registry Data - Analysis of the factors of decline in ADL among inpatients: Using COVID-19 Registry Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048334
Enrollment
9000
Registered
2022-07-11
Start date
2020-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: National case data registered with COVIREGI-JP and approved for use by the secretariat after undergoing prescribed procedure

Exclusion criteria

Exclusion criteria: *Cases in which neither the item of decreased self-care ability nor the item of decreased walking ability is described. *COVIREGI-JP secretariat goes to research Those who judge that the incorporation of

Design outcomes

Primary

MeasureTime frame
*Self-care ability at discharge compared to before onset *Gender and age *height,weight *comorbidities *immunosuppressive state at the time of admission *steroid use *oxygen use * method of oxygen administration *Invasive mechanical ventilation *ECMO *muscle relaxant *tracheostomy *prone position therapy *outcome *Tracheostomy at discharge *Oxygen administration at discharge * Renal replacement therapy or dialysis at discharge

Secondary

MeasureTime frame
*Walk ability at discharge compared to before onset *Gender and age *height,weight *comorbidities *immunosuppressive state at the time of admission *steroid use *oxygen use * method of oxygen administration *Invasive mechanical ventilation *ECMO *muscle relaxant *tracheostomy *prone position therapy *outcome *Tracheostomy at discharge *Oxygen administration at discharge * Renal replacement therapy or dialysis at discharge

Countries

Japan

Contacts

Public ContactKazuko Kikuchi

National Center for Global Health and Medicine department of rehabilitation medicine

kkikuchi@hosp.ncgm.go.jp0332027181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026